Greetings from Tom Moore! I’m the Chairman and CEO of Advaxis, a clinical-stage biotechnology company that is enthusiastic about what we do. I want to share with you what makes our company unique among next generation immunotherapies- our technology and our people. This blog is intended to provide insight into recent developments in biotechnology and [...]
Read More »-
Tom Moore is the Chairman and CEO of Advaxis, a clinical-stage biotechnology company developing the next generation of immunotherapies.
Tom also serves on several boards including Mayan Pigments, Inc., Healogix, Inc., Opt-e-scrip, Inc., and StoryCorps, Inc.